IMVT
Immunovant Inc
NASDAQ: IMVT · HEALTHCARE · BIOTECHNOLOGY
$26.95
-0.15% today
Updated 2026-04-29
Market cap
$5.49B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.67
Dividend yield
—
52W range
$13 – $30
Volume
1.4M
Immunovant Inc (IMVT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-69.40%
ROA
-41.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | — | $-136.74M | — | — | — |
| 2018 | — | $-450.00 | — | — | — |
| 2019 | — | $-450.00 | — | — | — |
| 2020 | $0.00 | $-66.39M | — | — | — |
| 2021 | $0.00 | $-107.43M | — | — | — |
| 2022 | $0.00 | $-156.73M | — | — | — |
| 2023 | $0.00 | $-210.96M | — | — | — |
| 2024 | $0.00 | $-259.34M | — | — | — |
| 2025 | $0.00 | $-413.84M | — | — | — |